临床相关性和miRNAs之间的相互作用在影响质母细胞瘤多种类型的预后

Samantha Epistolio1, Giulia Dazio1, Ismail Zaed2

  • 1Laboratory of Genetics and Molecular Pathology, Institute of Pathology, Ente Ospedaliero Cantonale (EOC), 6900 Locarno, Switzerland.

Cells
|February 9, 2024
PubMed
概括

特定的微RNA (miRNA) 配对对用temozolomide (TMZ) 治疗的多形质母细胞瘤 (GBM) 患者的生存率产生影响. 与miR-181c或miR-181d一起的miR-648的低表达表明GBM的预后更差.